The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will study the impact of a weight-loss drug on work and productivity.

All the evidence gathered from the five-year trial will be used to demonstrate the long-term effect of weight loss medication. Those behind the study say the results could help develop the care pathways set by health services for treating people with obesity.

The Prime Minister said the anti-obesity medication could help people "get back into work" and reduce pressure on the NHS, while Labour leader Sir Keir Starmer said it could also help ease pressure on